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Abstract
Background: Trypanosomatids utilise polycistronic transcription for production of the vast
majority of protein-coding mRNAs, which operates in the absence of gene-specific promoters.
Resolution of nascent transcripts by polyadenylation and trans-splicing, together with specific rates
of mRNA turnover, serve to generate steady state transcript levels that can differ in abundance
across several orders of magnitude and can be developmentally regulated. We used a targeted
oligonucleotide microarray, representing the strongly developmentally-regulated T. brucei
membrane trafficking system and ~10% of the Trypanosoma brucei genome, to investigate both
between-stage, or differentiation-dependent, transcriptome changes and within-stage flexibility in
response to various challenges.
Results: 6% of the gene cohort are developmentally regulated, including several small GTPases,
SNAREs, vesicle coat factors and protein kinases both consistent with and extending previous data.
Therefore substantial differentiation-dependent remodeling of the trypanosome transcriptome is
associated with membrane transport. Both the microarray and qRT-PCR were then used to analyse
transcriptome changes resulting from specific gene over-expression, knockdown, altered culture
conditions and chemical stress. Firstly, manipulation of Rab5 expression results in co-ordinate
changes to clathrin protein expression levels and endocytotic activity, but no detectable changes
to steady-state mRNA levels, which indicates that the effect is mediated post-transcriptionally.
Secondly, knockdown of clathrin or the variant surface glycoprotein failed to perturb transcription.
Thirdly, exposure to dithiothreitol or tunicamycin revealed no evidence for a classical unfolded
protein response, mediated in higher eukaryotes by transcriptional changes. Finally, altered serum
levels invoked little transcriptome alteration beyond changes to expression of ESAG6/7, the
transferrin receptor.
Conclusion: While trypanosomes regulate mRNA abundance to effect the major changes
accompanying differentiation, a given differentiated state appears transcriptionally inflexible. The
implications of the absence of a transcriptome response in trypanosomes for both virulence and
models of life cycle progression are discussed.
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Trypanosoma brucei is the causative agent of sleeping sick-
ness in humans and N'gana in cattle, and has a major eco-
nomic and morbidity impact across much of Africa [1].
The principal mechanism of immune evasion in the
mammalian host is antigenic variation, sequential expres-
sion of immunologically distinct variant surface glycopro-
teins (VSGs) at the cell surface [2], but additional
mechanisms, including manipulation of the host
immune system and antibody clearance from the surface
also participate [3-5]. The full impact of these mecha-
nisms on virulence is not understood at this time. The
mammalian part of the life cycle is complex, involving
penetration of multiple tissue spaces in the mammalian
host, encompassing the bloodstream, lymphatic system
and central nervous systems. Despite morphological sim-
ilarities between mammalian forms, it is unknown if a
developmental stimulus is required for tissue tropism or if
this results from stochastic events. Further, differentiation
to the procyclic insect form on entering the tsetse fly vec-
tor is accompanied by massive cellular remodeling,
including replacement of the VSG coat with procyclins, a
family of acidic glycoproteins, activation of the mitochon-
drion, changes to cellular and organelle morphology,
altered cell cycle checkpoints and attenuation of endocytic
activity [6-10]. Multiple stages have been described during
fly infection, with clear changes in morphology and sur-
face antigen expression [7,11,12]. How these alterations
are controlled at the transcriptional level remains unclear;
for example each form could represent a distinct develop-
mental stage, implying stimulus-driven differentiation, or
result from transcriptome flexibility, allowing modula-
tion of levels of certain transcripts in response to altered
conditions.
Polycistronic transcription in trypanosomes [13] pre-
cludes promoter-driven control of transcription, while
specific degradation appears to be the major mechanism
underpinning regulation of mRNA steady state levels.
Microarray hybridization and real time (RT) PCR meth-
ods can monitor steady-state RNA levels, and are inde-
pendent of mechanisms controlling mRNA abundance.
An earlier whole genome microarray study [14] identified
~2% of ORFs as developmentally regulated, but several
developmentally regulated factors, including the clathrin
heavy chain and Rab11 [10,15,16] were not detected in
that analysis.
Membrane trafficking is a defining characteristic of
eukaryotic cells, playing major roles in nutrient uptake,
turnover, signalling, immune defence, apoptosis and
many other processes. Mechanisms regulating transport
remain only partly understood in any organism, but tran-
scriptional, post-transcriptional and post-translational
processes are all implicated, with changes in transcription
[17], complex kinase integration [18], and formation of
multiple protein-protein interactions [19,20] contribut-
ing to control. Further, copious evidence implicates small
GTPases in regulating distinct aspects of transport, includ-
ing Rabs in vesicle fusion [21], ARFs in regulation of
membrane coat systems [22] and Rho-related proteins in
cytoskeletal interactions [23,24]. Expression profiling for
multiple human and mouse tissues indicates correlations
between expression of certain Rabs and the SNAREs,
adaptors, and other proteins with which they interact [17]
and facilitates construction of potential interaction hubs
and prediction of novel pathways.
Understanding of membrane transport is comparatively
advanced in trypanosomes [25,26], and various cellular
changes are associated with life cycle progression [6],
most notably an order of magnitude increase in endocytic
activity in the mammalian infective bloodstream form
(BSF) versus the insect procyclic (PCF) stages [10].
Increased endocytic activity in the BSF is likely related to
immune evasion [4,26,27]. By contrast, knowledge of
trypanosome signal transduction is poor [28]. Few Ras-
like GTPases or their corresponding regulatory factors are
present in trypanosomes, heterotrimeric GTPases are
absent and there are no obvious receptor-type tyrosine
kinases [29-31]. There is a complex predicted trypano-
some kinome [31] but limited understanding as to how
signaling is mediated via these factors [32-34]. There is
evidence for phosphatidylinositol-mediated signaling,
but this is comparatively unexplored [35], and a large
novel family of receptor-coupled adenylate cyclases in
kinetoplastids argues for significant environmental sens-
ing via novel mechanisms [36,37].
We selected the trypanosome trafficking system as a clear
example of a developmentally regulated process, where
sufficient data are available for meaningful investigation
of transcriptome changes. Using microarray analysis and
quantitative RT-PCR, we assessed developmental regula-
tion of trypanosome membrane transport and transcrip-
tional flexibility by targeted genetic manipulation and
altered environmental conditions designed to modulate
trafficking pathways. From work in other organisms, we
anticipated the involvement of protein kinases, small
GTPases and, in the case of the unfolded protein response
(UPR), a system that responds to increased concentrations
of non-native polypeptides within the endoplasmic retic-
ulum, clear evidence for a transcriptional mechanism.
Our data indicates developmental remodeling of the tran-
scriptome, but essentially no response to altered condi-
tions.Page 2 of 28
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Microarray design
Due to limitations of ORF assignment for specific spots of
the previously described whole genome microarray plat-
form [14], we designed a more targeted and fully vali-
dated array to address developmental regulation of the
trafficking system in T. brucei. Major classes of proteins
involved in membrane transport include small GTPases,
vesicle coats proteins, kinases and phosphatases, motility
factors mediating movement of vesicles along cytoskeletal
elements, tethering factors for binding of vesicles to target
membranes, SNARE proteins, ESCRTs and numerous
other molecules involved in protein sorting and mem-
brane deformation. The trypanosome genome was parsed
extensively for such factors [38-41] and, based on these
and additional searches, a subgenome microarray was
constructed. The array also included putative ER chaper-
ones, peptidases bearing an ER signal peptide and poten-
tially involved in degradation within the trafficking
system, homologues of kinases implicated in membrane
traffic in other systems [18], sphingolipid biosynthesis
enzymes with roles in exocytosis of glycosylphosphati-
dylinositol (GPI)-anchored proteins, as well as trypano-
some-specific surface antigens, e.g. BARP, CRAM, and the
invariant surface glycoprotein family, or ISGs [42-44]. In
addition we also included oligonucleotides against
ESAG6 and ESAG7, which encode the trypanosome trans-
ferrin receptor, a molecule reported to exhibit expression
that is modulated by growth conditions [45].
673 ORFs in the T. brucei genome with a potential role in
membrane trafficking were identified, representing ~8%
of the predicted protein coding potential. Representatives
of most components of the major gene families are found
in the T. brucei genome, but notable exceptions are the
absence of several coat systems [46], a relatively small
number of GTPases and associated factors [30], and the
absence of BAR and SH2 domains; BAR domains are used
extensively for membrane deformation in higher eukary-
otes [47], while the absence of SH2 domains may indicate
limited or unconventional signalling through protein
tyrosine kinase pathways [40,48]. Apart from clustering of
multicopy genes, there is no location bias for a specific
chromosome or region within a chromosome for these
ORFs [see Additional file 1]. An additional 123 ORFs were
also included as a reference. The first array (v1.0), used for
comparison of life stages and analysis of Rab5 isoform
over-expression, comprised 694 oligonucleotides, 56 of
which targeted reference ORFs. A modified array (v1.1),
used for all other analyses, included an additional 49 oli-
gonucleotides. The vast majority of oligonucelotides are
gene-specific but some are expected to hybridise to multi-
ple transcripts from multicopy genes [see Additional file
2].
Overview of differential expression between trypanosome 
life-stages
We extracted RNA from exponentially growing cultures of
T. brucei bloodstream and procyclic forms, labelled and
competitively hybridised the cDNA to the microarray. As
expected, the majority of genes were equivalently
expressed in the two life stages, but a small cohort did
present significant differential expression (Figure 1). The
heat-map (Figure 1B) indicates that the data for the most
significantly developmentally regulated genes are highly
reproducible across all replicates (8 arrays, 4 replicate
spots per array).
To identify which mRNAs are differentially expressed,
limma and fspma packages were used to interrogate the
data [49-51]. For comparison with previous work [14],
ratios above 2.5 (+/- 1.325, log2 scale) were considered
highly significant. Using this threshold, 8% of the genes
represented on the array are upregulated in BSF and 5% in
PCF, but excluding the reference set these numbers reduce
to 4% in BSF and 2% in PCF. Using a whole genome
microarray, Brems and cowrokers found only 2% of
trypanosome genes were developmentally regulated, and
while different pre-processing steps, in both mRNA prep-
aration and data analysis, make direct comparison diffi-
cult, the present data suggest that the trafficking cohort
likely exhibits bias in developmental regulation. There is
also greater upregulation in BSFs compared to PCFs, con-
sistent with increased activity in the trafficking system in
bloodstream stages [10]. Brems et al. found 80 genes
upregulated in PCF and 34 in BSF while, using the same
threshold, the present analysis identifies 16 upregulated
in PCF and 34 in BSF, from a much smaller cohort. These
data suggest that significant transcriptional level remodel-
ling of the membrane trafficking system accompanies life-
cycle progression in trypanosomes.
Strongly developmentally regulated genes include several
reference ORFs with known regulated expression, i.e
mRNAs for procyclin, trans-sialidase, CRAM, CAP17, and
CAP5.5 are increased in PCF, while ESAG6, ESAG7,
ISG65, ISG75, GPI-PLC, and CAP15 are upregulated in
BSF (Table 1). These data are fully consistent with previ-
ous work and support the validity of the microarray
approach for identifying previously uncharacterised
developmentally expressed genes. Rab11, also develop-
mentally regulated [15], gave an expression ratio below
2.5 by both limma and fspma analysis. Hence, analysis
using a more relaxed threshold to identify developmen-
tally regulated mRNAs was also used. Table 1 lists all ORFs
which either gave a ratio above 2.0 (+/- 1.00, log2 scale) by
limma or fspma analysis, or which had a B-statistic value
greater than 1.0 in limma, indicating statistical signifi-
cance in differential expression, despite a low relative
expression ratio. Excluding the reference set, 101 genesPage 3 of 28
(page number not for citation purposes)
BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298
Page 4 of 28
(page number not for citation purposes)
Overview of developmental transcriptome changes in the membrane trafficking system of trypanosomesFigure 1
Overview of developmental transcriptome changes in the membrane trafficking system of trypanosomes. Panel A: Scatter plot of raw data for all 3600 spots on 
a representative microarray used for developmental expression experiments. Cy5 fluorescence is plotted on the Y-axis (bloodstream, BSF) and Cy3 fluorescence on the X-axis 
(procyclic, PCF). Spots with a BSF/PCF ratio above two are highlighted in red, while spots with a PCF/BSF ratio above two are highlighted in green. Panel B: Clustering of the data 
for eight microarray experiments comparing BSF to PCF, representing four biological replicates plus relevant dye-swaps. The scale indicates the colour scheme for the z-score of 
the data, i.e. how far and in what direction, the ratio for each spot deviates from the mean for each array, expressed in units of standard deviation; bright red indicates significant 
upregulation in BSF, bright green indicates significant upregulation in PCF, dark colours or black indicate no differential expression between the two developmental stages. For 
each target gene, the four replicate spots on the array were averaged. White indicates data points rejected because of too much variability in the replicate spots. A small but sig-
nificant number of ORFs exhibit strong developmental regulation.
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BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298Table 1: Transcripts differentially expressed between the procyclic and bloodstream forms of T. brucei.
A
Upregulated in the procyclic form
PCF/BSF ratio
Accession Name limma fspma RT-PCR Classification
*Tb10.6k15.0030 procyclin 22.3 34.6 Cell surface
*Tb927.6.450 procyclin 21.9 17.0 Cell surface
Tb927.7.6850 trans-sialidase 5.0 4.7 Cell surface
Tb10.6k15.3510 CRAM 3.8 3.8 Cell surface
*Tb09.244.2460 BARP 1.9 1.9 1.6 Cell surface
Tb11.01.8120 hypothetical ER chaperone 3.0 3.0 2.8 Chaperones
*Tb927.6.3740 Hsp70 mitochondrial 2.3 4.2 Chaperones
*Tb10.70.0280 Hsp60 chaperonin mitochondrial 2.0 2.1 Chaperones
Tb11.01.3110 Hsc70 1.6 2.8 Chaperones
*Tb927.8.1610 Gp63 (TbMSP-B) 3.3 5.6 3.8 Proteases
Tb11.02.1480 mitochondrial processing peptidase 5.6 5.1 5.6 Proteases
Tb09.211.4760 MCA5 metacaspase 2.2 2.1 1.3 Proteases
Tb10.61.0870 v-SNARE 2.9 2.8 SNAREs
Tb927.4.2020 AP3 mu 2.1 2.2 Vesicle coat
Tb927.4.4350 emp24 2.1 1.9 1.0 Vesicle coat
Tb927.3.4020 PI4K alpha 2.2 2.1 1.7 PI kinases
Tb10.6k15.2060 PI3K (FRAP1) 2.0 2.0 PI kinases
Tb11.01.7800 NDPK kinase (NME6) 2.7 4.4 Other kinases
Tb11.03.0090 ribokinase (RBSK) 2.7 3.4 Other kinases
Tb927.3.3190 NEK kinase (NEK2/6/7) 2.5 2.9 Other kinases
Tb10.389.0330 UGP2 2.4 2.2 Other kinases
Tb927.6.710 DPCK kinase 2.0 2.0 Other kinases
*Tb09.211.3540 glk1 (CARKL) 1.4 2.9 Other kinases
*Tb09.160.4560 AK 1.4 2.8 Other kinases
*Tb927.1.720 PGKA (PGK1) 1.9 2.4 Other kinases
Tb11.02.0580 Vps46 2.4 2.8 ESCRT
Tb927.2.4210 p60 glycosomal protein 9.9 7.4 Other trafficking
Tb11.01.7880 CAP17 4.5 3.3 Other trafficking
Tb927.4.3950 CAP5.5 4.1 3.2 8.0 Other trafficking
Tb927.7.2640 Sec34-like 8.3 7.9 3.7 Other trafficking
Tb11.01.2540 VHS domain-containing protein 2.6 2.8 Other trafficking
Tb11.47.0022 signal-peptide-containing protein 3.1 2.7 Other trafficking
Tb10.406.0240 dual specificity protein phosphatase 2.1 2.6 Other trafficking
Tb927.1.3110 Sec17/SNAP 1.8 2.5 Other trafficking
Tb09.160.3240 C2 domain-containing protein 2.0 1.9 Other trafficking
Tb927.7.3550 C2 domain-containing protein 1.8 2.5 Other trafficking
Tb10.100.0130 peroxin 14 2.1 1.9 Other traffickingPage 5 of 28
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Tb927.8.7120 farnesyltransferase 2.6 2.5 Miscellaneous
*Tb10.406.0330 histone H2B 2.5 2.8 1.0 Miscellaneous
*Tb927.3.1370 40S ribosomal protein S25 2.4 3.2 1.5 Miscellaneous
Tb11.02.5250 histone H2B, variant 2.3 1.7 0.9 Miscellaneous
*Tb927.1.2430 histone H3 2.2 2.9 1.1 Miscellaneous
*Tb927.1.2400 alpha tubulin 1.7 3.0 0.8 Miscellaneous
Tb927.8.4010 fla1 1.8 2.2 Miscellaneous
Tb11.01.1650 SRP54-like 2.0 2.3 Miscellaneous
Tb927.3.3020 actin-like 1.5 2.7 Miscellaneous
B
Upregulated in the bloodstream form
BSF/PCF ratio
Accession Name limma fspma RT-PCR Classification
*H25N7.15 ESAG6 52.0 27.7 Cell surface
*N19B2.155 ESAG7 27.7 22.8 Cell surface
*Tb927.5.1410 ISG65 14.8 9.6 Cell surface
*Tb927.2.3270 ISG65 7.2 4.8 Cell surface
*Tb927.2.3280 ISG65 7.0 5.5 Cell surface
*Tb927.2.3320 ISG65 6.4 3.9 Cell surface
*Tb927.5.390 ISG75 5.8 8.2 Cell surface
Tb11.47.0001 ISG65 2.4 1.7 Cell surface
*Tb09.244.2430 BARP 2.4 2.4 Cell surface
*Tb927.5.360 ISG75 2.3 2.4 Cell surface
Tb927.7.5790 PDI/ERp44 2.5 2.8 Chaperones
Tb11.01.2640 hypothetical ER chaperone 2.3 2.2 1.0 Chaperones
Tb927.3.3450 ARL3A 7.0 5.9 7.8 small GTPases
*Tb05.5K5.230 Rab1b 7.0 8.2 small GTPases
Tb927.4.2380 HSR1-related GTP-binding protein 3.9 3.4 5.2 small GTPases
*Tb927.5.4590 Rab1b 3.8 5.7 small GTPases
*Tb09.244.2070 Rab1b 3.5 2.4 small GTPases
Tb927.8.8140 TbRX3 2.8 2.4 small GTPases
Tb10.70.0590 TbRHP 2.3 2.1 small GTPases
Tb11.01.6670 RabX3 2.3 2.1 4.8 small GTPases
Tb927.8.4330 Rab11a 2.3 2.0 1.9 small GTPases
*Tb09.211.4460 TbARF1 2.0 2.0 small GTPases
Tb10.70.5290 Gp63 (TbMSP-C) 4.7 3.3 6.2 Proteases
Tb927.3.4230 Ser peptidase (sybtilisin-like) 5.6 7.5 3.3 Proteases
Tb09.211.0680 CAAX prenyl protease 1 2.5 2.3 2.7 Proteases
Tb11.02.1280 Ser peptidase (sybtilisin-like) 2.5 2.2 1.1 Proteases
*Tb927.6.930 MCA3 metacaspase 2.3 1.9 1.8 Proteases
Tb927.7.190 OPA Thimet oligopeptidase 2.1 2.0 1.2 Proteases
Tb09.160.2420 syntaxin 3.6 2.6 SNAREs
Tb927.7.6440 v-SNARE 2.9 3.5 SNAREs
Tb927.3.3720 t-SNARE (Bet1) 2.5 2.7 SNAREs
Tb09.211.3920 t-SNARE 2.5 1.8 1.8 SNAREs
Table 1: Transcripts differentially expressed between the procyclic and bloodstream forms of T. brucei. (Continued)Page 6 of 28
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Tb10.389.0480 Vps16 1.9 2.8 Tethers
Tb10.61.1910 CLL 3.1 2.5 4.2 Vesicle coat
Tb927.3.4000 AP1 sigma 6.0 7.0 Vesicle coat
Tb11.01.6880 emp24 2.1 2.2 1.7 Vesicle coat
*Tb11.50.0006 epsin-like protein 2.0 2.1 2.5 Vesicle coat
Tb11.01.6980 PI3K (FYVE domain) 7.5 10.3 PI kinases
Tb927.8.7110 Ser/Thr kinase NEK7-like (PH domain) 2.6 2.1 PI kinases
Tb10.70.2440 PIK5KII 2.1 2.6 PI kinases
*Tb927.4.5310 Ser/Thr kinase A (PH domain) 1.9 1.7 PI kinases
*Tb10.70.5800 hexokinase (GCK/HK) 3.8 3.8 Other kinases
Tb927.6.1780 MAP kinase (MAPK8/9) 2.9 2.3 Other kinases
Tb927.4.3770 calcium-dependent protein kinase (CAMK4) 2.5 3.2 Other kinases
Tb10.61.2680 pyruvate kinase (PKLR) 2.2 1.8 Other kinases
Tb10.61.2490 MAP kinase kinase kinase (MAP3K8) 2.2 2.0 Other kinases
Tb10.70.1130 two UIM domain-containing protein 8.8 5.9 Ubiquitin sorting
Tb11.46.0014 Doa4 (Ubiquitin C-term hydrolase) 2.7 2.9 Ubiquitin sorting
Tb09.211.3610 UBA2/E1 2.3 2.4 2.5 Ubiquitin sorting
Tb927.6.2370 Ubiquitin-protein ligase 2.2 2.2 Ubiquitin sorting
Tb927.4.2710 E2 1.6 2.5 1.6 Ubiquitin sorting
Tb927.2.6000 GPI-PLC 8.7 8.0 Other trafficking
Tb11.01.3805 CAP15 4.3 4.8 Other trafficking
Tb09.211.4240 sorting nexin 2 (PX domain) 3.4 4.8 Other trafficking
Tb10.70.4620 gamma SNAP 2.7 2.5 Other trafficking
Tb927.4.2070 giantin 3.1 1.8 Other trafficking
Tb927.6.3500 RME-8 endosome trafficking 2.8 2.2 2.3 Other trafficking
Tb11.01.4460 scavenger receptor 3.0 2.8 Other trafficking
Tb927.5.4520 Uso1p-like (spectrin repeat) 2.7 1.8 Other trafficking
Tb927.5.3220 Sec11 2.4 3.4 Other trafficking
Tb11.01.6260 Sec63 2.3 2.3 Other trafficking
Tb927.1.1560 NSF 2.2 1.7 Other trafficking
Tb10.70.5100 lysosomal alpha-mannosidase 2.2 1.8 Other trafficking
Tb11.02.1370 katanin/Ser peptidase 1.7 1.7 Other trafficking
Tb927.4.2080 C2 domain-containing protein 1.9 1.8 Other trafficking
*Tb927.5.420 ISG65-like 3.5 5.1 Miscellaneous
Tb927.5.310 ISG-like 3.3 3.2 Miscellaneous
*Tb927.8.4060 fla2 (fla1-like) 3.5 2.6 Miscellaneous
Tb10.61.1090 H3 variant 2.3 2.9 1.8 Miscellaneous
Tb10.406.0320 ARPC5 2.2 2.5 Miscellaneous
Tb927.5.630 ISG65-like 2.2 2.4 Miscellaneous
Tb927.5.430 ISG65-like 2.2 2.1 Miscellaneous
ORFs represented by oligonucleotides on the array which gave a PCF to BSF expression ratio (panel A) or BSF to PCF 
expression (panel B) greater than two by limma or fpmsa analysis, or which had a value of over one for the B statistic in 
limma are shown. Limma ratios which correspond to a B value of >1 are given in bold. For candidates validated by qRT-PCR, 
the resulting qRT-PCR ratio is also given. Ratios below two may not be significant. The names of well-characterised genes 
which can be used as controls to validate the array results are in bold. Asterisk indicates oligonucleotides that hybridise with 
mRNA derived from more than one ORF [see Additional file 2].
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tially expressed in T. brucei; 64 upregulated in BSF, 37 in
PCF, i.e. 8% and 5% respectively.
25% of the most significantly developmentally regulated
genes were validated by qRT-PCR analysis, using the same
mRNA samples as used for the microarray analysis. The
vast majority of ORFs tested exhibited congruence
between qRT-PCR and microarray analysis, i.e. differential
regulation in the same direction (BSF or PCF, Table 1).
Significantly, all ORFs with a ratio above 2.5 on the array
also gave a significant ratio (i.e. above 2) in qRT-PCR. Two
genes with known developmental regulation, the clathrin
heavy chain [10,16] and TbMSP-A [52], did not demon-
strate significant differential regulation by microarray
analysis, but highly significant ratios were obtained by
qRT-PCR (data not shown). Various factors may be
responsible for this array artefact, which were not pursued
further; however these data specifically highlight exam-
ples of false-negative data in microarray analysis.
Differential expression of trafficking factors in 
trypanosomes
Considering the differentially expressed genes by func-
tional class indicates that a broad remodelling accompa-
nies differentiation, i.e. developmental changes are not
restricted to specific protein classes or pathways. Specifi-
cally, members of the chaperones, some proteases and
non-PI kinases are upregulated in PCF, while the small
GTPases, additional proteases, SNARE proteins and PI
kinases represent the major factors upregulated in BSFs
(Figure 2, Additional file 6). An increased requirement for
chaperones may be due to the greater heterogeneity of the
procyclic cell surface compared to the bloodstream form,
the latter being dominated by VSG. A differential require-
ment for secretory pathway proteases is consistent with
distinct roles for these molecules between the two life
stages, while upregulation of both small GTPases and
SNARE proteins in BSFs is broadly consistent with
increased activity within the trafficking system in the
mammalian stage.
Specificity and control factors
The most abundantly expressed small GTPases at the
mRNA level are Ran, ARL3A, both Rab1A and Rab1B, and
several members of the Arf subfamily (Figure 3). Ran is a
very abundant protein in most cells, while high expres-
sion of Arf1, Rab1, and ARL3A possibly suggest a consid-
erable emphasis on flux through the ER and Golgi
complex and flagellum biogenesis respectively [53-55].
Developmentally expressed small GTPases are restricted
to the BSF. This cohort includes markers for the recycling
endosome, Rab11 [15], the endosomes/Golgi, TbArf1
[53], and the flagellum, TbArl3A [55]. Identification of
Rab11 is consistent with earlier work [15] and our data
provide the first evidence for developmental regulation of
TbArf1 and TbArl3A. The data also identify Rab1B, RabX3,
Ras-like GTPases TbRX3 and TbRHP, and a putative
GTPase with an Hsr1 domain (Tb927.4.2380) as develop-
mentally regulated; with no experimental information for
these proteins the significance of these changes is not clear
[29,56]. Importantly, we see no strong developmental reg-
ulation for any of the putative GTPase-activating proteins
(GAPs) and guanine nucleotide exchange factors (GEFs)
included in the study. Some developmental regulation of
TBC family Rab-GAPs is detectable by qRT-PCR, but at lev-
els unlikely to be detected by the array (C. Gabernet-Cas-
tello and MCF, unpublished data).
In addition to a number of small GTPases, including Rab
subfamily members, five predicted SNARE mRNAs exhibit
increased expression in BSFs (Table 1). While no direct
experimental information is available for these molecules,
Tb09.211.3920, the most abundant Qa SNARE at the
mRNA level (Figure 3), is likely involved in post-Golgi
transport on account of similarity to trans-Golgi network
(TGN) SNAREs SYP42 from Arabidopsis thaliana and
syntaxin16/Tlg2p from S. cerevisiae [57,58], while the L.
major orthologue, LmjF35.2720, localises close to the
Golgi complex [59]. Tb10.70.7410 and Tb09.160.2420
are similar to the A. thaliana early endosomal SNARE
VAMP727 and the ER-located SYP72, respectively [58],
Significantly developmentally expressed trypanosome genes grouped b functi nal classFig r  2
Significantly developmentally expressed trypano-
some genes grouped by functional class. Genes repre-
sented by array oligonucleotides were grouped by function, 
based on sequence similarity to annotated sequences, 
domain annotation, GO terms and additional criteria. The 
proportion in each functional class significantly upregulated in 
BSF are shown in red and in PCF in green. The remaining 
fraction of genes in each class are shown in grey. The first bar 
illustrates the proportion of developmentally regulated tran-
scripts in the entire studied gene cohort. For raw data [see 
Additional file 6].
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Relative steady state mRNA levels of selected trypanosome genesFigure 3
Relative steady state mRNA levels of selected trypanosome genes. Fluorescence intensity data for eight microarray 
experiments comparing BSF to PCF, representing four biological replicates plus dye-swaps, was normalised to the total signal 
intensity of each slide, averaged and plotted as bar-graphs against ORF designation or accession number. Error bars indicate 
the standard deviation, dark bars are BSF and light bars PCF. Panel A: Small GTPases. ARL and Rab annotations are based on 
[39], Ras-like annotations based on [29] and additional data at GeneDB. Panel B: Cell surface proteins. Panel C: SNARE family 
proteins. Annotations based on domain architecture and similarity to sequences described for L. major [59]. Panel D: Putative 
secretory pathway proteases. ORFs were included for predicted proteases that bear an ER targeting sequence and/or a pre-
dicted trans-membrane domain. In each cohort, a limited number of transcripts are highly expressed.
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BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298while Tb927.7.6440 and Tb927.3.3720 do not display
significant similarity to any specific SNARE. By contrast,
Tb10.61.0870, is the only upregulated SNARE message in
the procyclic stage, with weak similarity to Aspergillus
Bos1, suggesting a putative role in anterior transport from
the ER; Tb10.61.0870 is also the most highly expressed
Qb SNARE (Figure 3). These data are suggestive of specific
upregulation of mRNAs encoding endocytic and exocytic
SNAREs in BSF, with evidence for limited PCF regulation
of the secretory pathway. On average, Qc and R SNAREs
are more highly expressed than Qa and Qb SNAREs (Fig-
ure 3). The T. brucei N-ethylmaleimide sensitive factor
(NSF, Tb927.1.1560), an ATPase responsible for regula-
tion of SNARE complex disassembly [60], and a hypothet-
ical protein similar to γ-soluble NSF attachment protein
(γ-SNAP, Tb10.70.4620) are upregulated in BSF, which
may indicate increased overall SNARE activity, but a fur-
ther putative SNAP (Tb927.1.3110) is upregulated in PCF.
Interestingly, both Tb927.1.1560 (NSF) and
Tb927.1.3110 (SNAP) have severe RNAi knockdown
growth phenotypes [61]. Expression of Vps16, a compo-
nent of the HOPS tethering complex functioning at the
late endosome, is increased in the BSF (Table 1). Overall,
multiple factors likely to be controlling endocytic path-
ways, encompassing SNAREs, Rabs and possibly also the
HOPS complex, appear more highly expressed in the BSF,
consistent with earlier data but also suggesting more
extensive remodelling than previously suspected.
Coat proteins
The vast majority of vesicle coat factor mRNAs are
expressed at equivalent levels in both major life stages. Of
those that are regulated, most notable is the clathrin light
chain, Tb10.61.1910, upregulated in BSF and in agree-
ment with increased endocytosis in this life stage [16].
Further, Tb11.01.6880, containing a predicted emp24
domain, suggesting a role as a cargo receptor in COPII-
mediated transport [62], is upregulated in BSF, whereas a
second emp24-related ORF, Tb927.4.4350, is upregulated
in PCF. Should these proteins indeed represent emp24
isoforms, this expression profile indicates potential devel-
opmental-stage specific remodelling of COPII cargo selec-
tion providing differentiation in ER exit pathways.
A putative epsinR (Tb11.50.0006), is also significantly
upregulated in BSF; epsinR is associated with clathrin
coated vesicles and AP1 [63]. The AP1 subunit is signifi-
cantly upregulated in BSF, but the μ-subunit of AP3, is
upregulated in PCF (Table 1); both complexes have a role
in endosome to TGN transport. Although no further adap-
tin components exhibit highly significant differential
expression, a general trend of upregulation of AP1 compo-
nent in BSFs and downregulation of AP3 and AP4 was evi-
dent on the microarray [see Additional file 3] which
suggests developmental regulation. From previous analy-
ses, the AP1 γ-subunit is constitutively expressed [64], but
the β-chain is upregulated in BSF [16], suggesting possible
subunit-specific regulation. To further confirm the signif-
icance of these data polyclonal antibodies were raised
against the δ-subunit of AP3. Western blotting confirmed
significant developmental regulation of AP3δ, with
expression greatly augmented in the PCF [see Additional
file 3]. These data are also consistent with evidence sug-
gesting increased emphasis on lysosomal trafficking in the
PCF [26,65].
Proteases
Several proteases are known components of the trypano-
some surface and endocytic system or predicted to be,
based on the presence of a signal peptide. The gp63 iso-
form TbMSP-B (Tb927.8.1610), is upregulated in PCF,
while TbMSP-C (Tb10.70.5290) is upregulated in BSF
(Table 1), confirming previous analyses [52]. TbMSP-A,
previously identified as BSF-specific [52], is only slightly
upregulated by microarray, but is validated strongly by
qRT-PCR (results not shown). Further, metacaspase
MCA3 (Tb927.6.930) showed significant upregulation in
BSF, also confirming earlier data [66]. Microarray data
indicate that MCA5 (Tb09.211.4760) is upregulated in
PCF, but qRT-PCR data failed to validate this, suggesting
more equivalent expression, also in agreement with ear-
lier work [66]. Two subtilysin-like serine peptidases
(Tb927.3.4230, Tb11.02.1280), a CAAX prenyl protease
(Tb09.211.0680), and a thimet oligopeptidase A
(Tb927.7.190) are upregulated in BSF. The thimet oli-
gopeptidase Tb927.7.190 was recently suggested to play a
role in dysregulated kinin metabolism observed in the
plasma of trypanosome-infected hosts and to contribute
to vascular lesions observed in African trypanosomiasis
[67], consistent with augmented expression in BSF.
The most abundant protease class message is for
Tb927.6.960, an L-cathepsin-like cysteine peptidase, and
likely a lysosomal protein [68], which appears equiva-
lently expressed in both life stages (Figure 3). Some of the
developmentally regulated proteases are also abundant at
the mRNA level (Figure 3), namely MSP-B
(Tb927.8.1610), MCA5 (Tb09.211.4760), a subtilysin-
like serine peptidase (Tb927.3.4230), and thimet oli-
gopeptidase A (Tb927.7.190). Hence the major proteo-
lytic activity likely resides within the cysteine protease
class, as previously reported [69], but these new data sug-
gest a significant level of developmental remodelling, as
well as potential contributions from additional protease
classes.
Chaperones and ER lumenal proteins
Several putative ER chaperones, likely to aid folding of
secreted coat proteins, were also studied. Of these,
Tb927.7.5790 is homologous to ERp44, a thioredoxin ofPage 10 of 28
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have a role in controlling the redox state of the ER, and is
upregulated in BSF [70]. Two additional PDI proteins are
also upregulated in the bloodstream stage of T. brucei
[71,72], suggesting remodelling of these factors between
life stages.
In the PCF stage, two predicted mitochondrial chaper-
ones, an Hsp70 (Tb927.6.3740) and an Hsp60
(Tb10.70.0280), are upregulated, consistent both with
previous data [73,74] and increased mitochondrial activ-
ity [6]. Additionally, an Hsp70 (Tb11.01.3110) with high
similarity to human Hsc70, an uncoating ATPase for
clathrin coated vesicles, is upregulated in PCF [75-77].
Since clathrin-mediated endocytosis is upregulated in BSF
but lysosomal targeting upregulated in PCF, these data
may indicate a role in lysosomal targeting, but there are
multiple Hsp70 ORFs in T. brucei and Hsp70 has been
previously reported to be upregulated slightly in BSF [78].
Two novel ER lumenal proteins, Tb11.01.2640 and
Tb11.01.8120, with a predicted signal peptide and C-ter-
minal HDEL ER-retrieval motif are developmentally regu-
lated, the former with augmented expression in BSF and
the latter in PCF. Both are localised to the ER, and give a
severe growth phenotype by RNAi knockdown, suggesting
an important function within the ER (T. Sergeenko and
MCF, unpublished data). Overall, the expression profile
of the chaperones does not provide evidence for substan-
tial differential remodelling of the ER folding environ-
ment, and may suggest a comparatively similar set of
factors are required for synthesis of the cell surface in PCF
and BSF, despite major differences in the structures of the
superabundant surface antigens.
Lipid kinases
Two highly conserved lipid kinases with roles in intracel-
lular trafficking are known in trypanosomes: Fab1
(Tb11.47.0002), a PI 5-kinase and TbVps34
(Tb927.8.6210), a PI 3-kinase involved in endocytosis
and Golgi segregation [35,46]. Neither of these factors
shows evidence for differential expression, but several
other predicted phosphatidylinositol kinases are develop-
mentally regulated (Table 1). A type III phosphatidyli-
nositol 4-kinase, Tb927.3.4020, highly similar to S.
cerevisiae Stt4p, is upregulated in PCF, consistent with a
recent report of a role for a type III PI 4-kinase in protein
trafficking, maintenance of Golgi and cell morphology
and cytokinesis in PCFs [79]. A predicted phosphatidyli-
nositol 3-kinase, Tb10.6k15.2060, is also upregulated in
PCF and most likely represents an atypical protein kinase
of the TOR-related family [35]. Significantly, human
FRAP1, a member of the TOR-related kinase family, is
required for clathrin-mediated endocytosis [18].
Tb11.01.6980, an atypical PI 3-kinase with a PI(3)P-bind-
ing FYVE domain and a putative N-terminal trans-mem-
brane helix is highly upregulated in BSF; on account of the
FYVE domain this protein is expected to localise to the
endosomal system [35]. Further, Tb10.70.2440, a pre-
dicted PI4P 5-kinase, is also upregulated in BSF, while two
serine threonine kinases with pleckstrin homology (PH)
domains, capable of recognising PI4,5P lipids, are upreg-
ulated in BSF. Taken together these data suggest signifi-
cant remodelling of the PI-based signalling system
between life stages, together with evidence for increased
expression of several putative endosomal functioning PI-
kinases in the BSF.
Protein kinases
A genome-wide analysis of the roles of kinases in clathrin-
and caveolin-mediated endocytosis was performed
recently in H. sapiens [18]; significantly, caveolin-medi-
ated endocytosis is restricted to the metazoa [46]. We
looked for orthologues of the kinases that gave an endo-
cytosis phenotype in the Pelkmans et al . study [18] and
included these in the array to analyse their differential
expression.
Two metabolic pathway kinases and three putative signal-
ling kinases are upregulated in BSF. These include
Tb10.70.5800, a glycosomal hexokinase, expected due to
increased glycolytic activity in BSFs [14,80]; this kinase is
similar to H. sapiens hexokinase II, required for clathrin-
mediated endocytosis [18]. Pyruvate kinase
(Tb10.61.2680) is also upregulated, in agreement with
earlier work [81], and interestingly the related H. sapiens
kinase, PKLR, inhibits caveolae-mediated endocytosis
[18]. The three signalling kinases upregulated in BSF all
show similarities to endocytosis kinases [18].
Tb927.6.1780, a putative MAP-kinase similar to human
MAPK8, is activated in response to temperature stress
[34]. A MAP-kinase kinase kinase, Tb10.61.2490, has sim-
ilarity to human MAP3K8, and finally a calcium-depend-
ent protein kinase, Tb927.4.3770, is highly similar to
CAMK4, which participates in a calcium/calmodulin-
dependent protein kinase cascade [82]. These data clearly
suggest a role for kinase activity in BSF trafficking.
Eight primarily metabolic pathway kinases are upregu-
lated in PCF. One is a nucleoside diphosphate kinase
(Tb11.01.7800) which is involved in the equilibration of
cellular pools of nucleotide triphosphates, and which
binds telomeres and acts as a Rho-GAP in other systems
[83-85]. This protein localises predominantly to the
nucleus in T. brucei [86] and shows similarity to human
NME6, found to inhibit clathrin-mediated endocytosis
[18]. A ribokinase (Tb11.03.0090) upregulated in PCF is
highly similar to human RBSK, required for clathrin-
mediated endocytosis [18]. A putative NEK kinase
(Tb927.3.3190) is related to human NEK2, 6, and 7, all of
which are required for clathrin-mediated endocytosisPage 11 of 28
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transferase 2 (Tb10.389.0330) is related to human UGP2,
required for clathrin-mediated endocytosis [18]. A glyco-
somal glycerol kinase (Tb09.211.3540) related to human
CARKL, which is required for caveolin/lipid raft-mediated
endocytosis [18], was upregulated in PCF, although
equivalent levels of specific activity for this enzyme have
been reported for both life stages [80,87]. An arginine
kinase (Tb09.160.4560) involved in the management of
cellular ATP energy reserves [88] is similar to human CKB,
required for clathrin-mediated endocytosis [18]. A puta-
tive dephospho-CoA kinase (Tb927.6.710) which cata-
lyzes the final step in CoA biosynthesis, is related to
human DPCK, which is required for caveolin/lipid raft-
mediated endocytosis [18]. A phosphoglycerate kinase
(Tb927.1.720), similar to human PGK1, which is
involved in both clathrin-mediated and caveolin/lipid
raft-mediated endocytosis [18] was up in PCF, consistent
with previous analyses for T. brucei PGKB [89], although
the oligonucleotide used does not allow us to differentiate
PGK isoforms. A putative Ser/Thr and Tyr dual specificity
phosphatase (Tb10.406.0240) possibly involved in MAP
kinase signalling, is also upregulated in PCF. Taken
together these data suggest multiple kinases are involved
in control of trafficking in both life stages, with more sig-
nalling kinases upregulated in BSF, and these data provide
a number of candidates for further analysis.
Ubiquitylation
Covalent attachment of ubiquitin to surface molecules is
an important mechanism for internalization and lyso-
somal targeting [90,91], and is present in trypanosomes
[92,93]. Five ORFs likely to participate in the trypano-
some ubiquitylation system are upregulated in BSF;
Tb09.211.3610, an ubiquitin-activating E1 enzyme,
Tb927.4.2710, an ubiquitin-conjugating E2 enzyme,
Tb927.6.2370, an ubiqutin ligase E3, Tb11.46.0014, an
ubiquitin carboxyl-terminal hydrolase similar to S. cerevi-
siae Doa4p protein, and Tb10.70.1130, which contains
two putative ubiquitin interaction motifs, but otherwise
has no predicted function. Upregulation of a near com-
plete pathway for protein ubiquitylation and deubiquit-
ylation in BSFs is suggestive of stage-specific
ubiquitylation, but clearly direct evidence is required [94].
RNAi of the E1 Tb09.211.3610 shows a strong growth
defect but does not affect the stability of ISG65, a surface
protein subject to ubiquitylation [93]. A protein contain-
ing a VHS domain (Tb11.01.2540) which is normally
found in the Vps27 component of ESCRT 0, and a putative
Vps46 component of the ESCRT III-associated complex
(Tb11.02.0580) are upregulated in procyclics, further sup-
porting differential regulation of the ubiquitin sorting sys-
tem.
Hypothetical open reading frames
A considerable fraction of the analysed ORFs are anno-
tated as hypothetical, and were included on account of
sequence features shared with characterized trafficking
factors. Several of these exhibit developmental regulation.
For example, the C2 domain is a Ca2+-dependent mem-
brane-targeting module [95-97]; two ORFs with predicted
C2 domains, Tb09.160.3240 and Tb927.7.3550, are
upregulated in procyclics, and one, Tb927.4.2080, is
upregulated in BSF. Interestingly, Tb927.7.3550 localises
between the inner face of the plasma membrane and the
sub-pellicular corset of microtubules in T. brucei, and
includes a highly charged region characteristic of a tubu-
lin-binding domain [98]. RNAi evidence indicates a clear
role for Tb927.7.3550 in cytoskeletal function [98].
Other hypothetical genes that show significant differential
regulation at the mRNA level are, in PCF: Tb927.7.2640,
which contains part of a Sec34 domain (although it is not
a true COG3/Sec34 orthologue [41]), and Tb11.47.0022,
which contains a signal peptide and a trans-membrane
helix; both ORFs are highly conserved between trypano-
somatids but have no identifiable orthologues in other
organisms. In BSF: Tb11.01.4460, which contains a
cysteine-rich repeat region found in the low-density lipo-
protein (LDL) receptor, and Tb927.5.4520, an extended
coiled-coil protein are upregulated. The flagellum adhe-
sion glycoprotein fla1 was upregulated in PCF, as has
been reported previously [99], but the closely related fla2
[100] was upregulated in BSF, indicating that the two gene
products may have similar functions but distinct expres-
sion patterns.
Surface antigens
Messages for BSF-specific ESAG6/7 and ISG65/75 surface
antigens are highly abundant (Figure 3). By contrast,
CRAM, a possible lipoprotein receptor abundant in PCF,
and BARP, a putative glycolipid-lipid raft associated pro-
tein are not so highly expressed (Figure 3). Interestingly,
some of the oligonucleotides for BARP showed upregula-
tion in PCF and some in BSF (Table 1); BSF-specific and
epimastigote-specific BARP expression have been reported
previously [12,44]. The differential expression levels for
the ISG75 mRNAs (Figure 3) represent mostly the degen-
eracy of each oligonucleotide [see Additional file 2], but
the mRNAs for the ISG65 genes on chromosome 5
(Tb927.5.1390-1410-1430) are clearly more abundant
than those for the ISG65 genes on chromosome 2
(Tb927.2.3280-3290-3300-3310). We also included oli-
gonucleotides for several ISG-like proteins, four of which,
Tb927.5.310, Tb927.5.420, Tb927.5.430, and
Tb927.5.630, are significantly upregulated in BSF, sug-
gesting additional and so far uncharacterised develop-
mental modification of the parasite surface.Page 12 of 28
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transcriptome
The detection of a significant cohort of developmentally
regulated trypanosome mRNAs by microarray, and their
validation by qRT-PCR, provided confidence that our pro-
cedure could be exploited for investigation of transcrip-
tome changes associated with differing conditions. In
several model organisms, the interactions between gene
products has been probed by analysis of coordinated
changes to the transcriptome in response to challenges to
the cell. Such studies have included several changes to
growth conditions, insult with specific chemicals to
invoke the unfolded protein response (UPR), and targeted
manipulations of gene expression [101-104]. Here we
used all three approaches to probe the T. brucei transcrip-
tome in order to determine the level of flexibility, and to
assess if such data could facilitate construction of interac-
tion and pathway maps based on coordinate expression
profiles.
Iron starvation
Bloodstream trypanosomes are sensitive to iron starva-
tion, and upregulate ESAG6/7 transferrin receptor (TfR)
mRNA and protein levels when placed in low transferrin
or iron-depleted media [45,105] and adjust TfR expres-
sion to compensate for reduced endocytosis [65]. Both
observations suggest a specific transcriptional-level
response resulting from an iron-sensing mechanism. The
transcriptomes of BSFs cultured in different proportions
of fetal bovine serum (FBS), in the absence of FBS or in the
absence of FBS but supplemented with bovine holo-trans-
ferrin were analysed. An increase in ESAG6/7 mRNA was
detected under FBS depletion by the array (Table 2),
which was validated by qRT-PCR in agreement with previ-
ous analyses [45,105]. mRNAs for procyclin, the gp63 iso-
form TbMSP-C (Tb10.70.5290) and the major cysteine
peptidase (Tb927.6.960) were upregulated in serum-
depleted cells (Table 2). In cells grown in 30% FBS, procy-
clin mRNA, as well as an ISG-like protein (Tb927.5.410)
and a putative calcium-dependent protein kinase
(Tb927.4.3770) were downregulated (Table 2), which
contrasts with a moderate upregulation of procyclin in
serum free conditions. These alterations were confirmed
by qRT-PCR, and may suggest a suppression of procyclin
expression by serum factors. However, overall there were
no additional transcriptome changes when cells were
grown in 30% FBS or in 0% FBS with or without transfer-
rin. Scatter plots of the entire array data set indicate few
transcripts that fall outside of the region considered as
equivalent, in marked contrast to the scattergram
obtained for developmental changes (compare Figure
4B–D with Figure 4A or Figure 1). These data suggest a
very limited and specific ability of the BSF to respond to
alterations in levels of nutrients, which may be restricted
primarily to ESAG6/7.
Unfolded protein response (UPR)
Transcriptome responsiveness was further tested by
attempts to invoke the UPR, a classic ER-based pathway
stimulated by the presence of increased levels of unfolded
polypeptides [106]. The UPR is mediated via transcrip-
tional responses in both yeast and metazoan cells
[104,107], and can be reliably activated by addition of
tunicamycin or dithiothreitol (DTT). Using tunicamycin
and DTT at concentrations that invoke a UPR in mamma-
lian cells, Arabidopsis, yeast and other systems [108-112],
we found that, in T. brucei, tunicamycin resulted in growth
arrest over a period of up to 24 hours, while DTT exposure
led to rapid cell death [see Additional file 4]. This concen-
tration of tunicamycin also efficiently inhibits trypano-
some N-glycosylation [113]. Therefore, we analysed the
transcriptome at 5 μg/ml and 1 mM for tunicamycin and
DTT, respectively, under conditions where cells remained
viable, as assessed by motility.
Essentially no significant change to the transcriptome was
observed by either treatment. Very few ORFs showed sig-
nificant differential regulation under DTT or tunicamycin
treatment, and scatterplots indicate few transcripts falling
outside of the equivalence region, in marked contrast to
developmental changes (Table 2, Figure 4E–H). Only one
hypothetical chaperone was upregulated after 4 hr in 1
mM DTT, while Rab11, ESAG7, and an ISG-like protein
(Tb927.5.410) were downregulated. By contrast, a PDI
class ORF, Tb10.6k15.2290, was downregulated after 24
hr of tunicamycin treatment, while ESAG6/7 as well as
procyclin were upregulated in cells treated with tunicamy-
cin (Table 2). Further, total cell lysates were examined for
increased expression of the major ER chaperone, BiP, by
Western blotting and qRT-PCR. No alteration in expres-
sion of this marker, which is rapidly and strongly induced
by the UPR in higher eukaryotes, was observed following
DTT or tunicamycin exposure [see Additional file 4].
These data indicate an essential lack of transcriptome
responsiveness to altered conditions by the trypanosome,
and specifically the complete absence of a classical UPR.
Significantly, this likely contributes to the extreme sensi-
tivity of trypanosomes to DTT.
Knockdown of clathrin and VSG
As an additional strategy for investigating transcriptome
responsiveness, the mRNAs of two highly important pro-
teins involved in endocytosis and surface architecture,
specifically the clathrin heavy chain (CLH) and VSG, were
suppressed with RNAi. Both proteins are essential and
CLH RNAi results in rapid cell death. For CLH, knock-
down leads to a complete block to endocytosis [114],
while VSG RNAi results in arrest of cell cycle progression
[115]. We hypothesized that if trypanosomes were able to
sense alterations in trafficking and respond to thesePage 13 of 28
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Fold up (down) vs control
Experiment Gene Accession array qRT-PCR
SMB grown with 0%FBS 5 mg/ml BSA vs with 
10% FBS
Gp63 (TbMSP-C) Tb10.70.5290 2.9 2.2
procyclin Tb10.6k15.0030 2.4 2.4
procyclin Tb927.6.450 2.0 2.3
cysteine peptidase Tb927.6.960 1.9 3.6
ESAG6 H25N7.15 1.8 3.9
ESAG7 N19B2.155 1.6 4.7
14-3-3-like Tb11.02.4700 (1.9)
SMB grown with 0%FBS, 5 mg/ml BSA, 0.3 mg/
mg Tfn vs with 10% FBS
Gp63 (TbMSP-C) Tb10.70.5290 3.1 1.5
procyclin Tb10.6k15.0030 2.2 1.9
cysteine peptidase Tb927.6.960 2.0 4.6
ESAG6 H25N7.15 2.0 4.1
ESAG7 N19B2.155 1.4 3.5
SMB grown with 30%FBS vs with 10% FBS ISG65-like Tb927.5.410 (2.9) (4.1)
CAMK4 kinase Tb927.4.3770 (2.2)
procyclin Tb10.6k15.0030 (1.9) (3.6)
SMB grown for 1 hr with 1 mM DTT vs without GTP1/OBG/Hsr1 Tb927.2.5060 2.4
putative ABC transporter Tb10.329.0040 2.2
ISG65-like Tb927.5.410 (2.9) (1.9)
ESAG7 N19B2.155 (2.2) (2.0)
MAP kinase Tb10.70.2070 (2.1)
Rab3GAP Tb10.6k15.1390 (2.1)
dual-specificity protein phosphatase Tb927.5.3620 (1.9)
SMB grown for 4 hr with 1 mM DTT vs without TbGRP Tb10.6k15.1520 3.6
hypothetical ER chaperone Tb11.01.8120 3.0 3.3
Ubiquitin conjugating Tb927.7.6960 2.8
Vta1-like Tb927.7.7140 2.7
syntaxin Tb10.61.1980 2.7
Hsp60 chaperonin Tb10.70.0280 (3.0)
GMP-PDE delta Tb927.2.4580 (2.8)
Rab11a Tb927.8.4330 (2.8) (1.8)
Ser peptidase (Bem46-like) Tb09.211.2310 (2.4)
Sec24 Tb927.3.5420 (2.4)
SMB grown for 4 hr with 5 ug/ml Tunicamycin 
vs without
procyclin Tb10.6k15.0030 2.4 2.1
ESAG6 H25N7.15 1.9 2.3
procyclin Tb927.6.450 1.7 2.3
AP2-kinase1 Tb09.160.4770 (2.0)
SMB grown for 24 hr with 5 ug/ml Tunicamycin 
vs without
procyclin Tb10.6k15.0030 4.2 7.8
procyclin Tb927.6.450 2.7 8.8
ESAG7 N19B2.155 2.6 4.3
ESAG6 H25N7.15 2.2 2.8
RabGAP Tb10.6k15.1790 2.1
GOLD domain Tb927.7.3600 2.1
PDI/ERp72 Tb10.6k15.2290 (2.3)
VSG RNAi induced vs uninduced Day1 RabGEF/Vps9 Tb927.3.2430 2.1Page 14 of 28
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be expected to elicit a response.
We analysed the transcriptome of cells 24 hours after
induction of the CLH RNAi, as the CLH protein levels are
significantly reduced at that stage [see Additional file 5],
growth is arrested, and the big eye morphology is clearly
visible (data not shown). Despite a clear phenotype, we
observed very limited transcriptome changes (Figure 4K,
Table 2). Only TbMSP-C and an ISG-like ORF
(Tb927.5.410) were significantly upregulated, while only
a putative Rab effector, GMP-PDEδ (Tb927.2.4580) and a
putative CBL-interacting protein kinase (Tb927.8.870)
were significantly downregulated (Table 2). For the VSG
RNAi, we analysed cells 24 and 72 hours after induction
to examine both early and late effects of VSG depletion.
No major transcriptome changes were observed (Figure
4I–J, Table 2) despite growth arrest [see Additional file 5].
Indeed, only one ORF, a putative RabGEF (Tb927.3.2430)
was significantly upregulated (Table 2). The absence of a
coordinated response within the transcriptome as a result
of these severe perturbations of cellular homeostasis sug-
gests that trypanosomes lack mechanisms for response at
the mRNA level to altered circumstances.
The transcriptome is unaltered in cells with augmented endocytic 
activity
As a final test of transcriptome responsiveness we ana-
lysed the effects of over-expression of the early endosome
small GTPases Rab5A and Rab5B in PCF, which results in
VSG RNAi induced vs uninduced Day3 nothing
CLH RNAi induced vs uninduced 24 hr Gp63 (TbMSP-C) Tb10.70.5290 2.7 3.6
ISG65-like Tb927.5.410 2.8 3.8
CLH Tb10.70.0830 (2.5)
GMP-PDE delta Tb927.2.4580 (2.3)
CBL-interacting protein kinase 9 Tb927.8.870 (2.0)
Rab5AWT overexpressing PCF line vs PCF WT 
(both with 20% FBS)
alpha tubulin Tb927.1.2400 2.9 1.7
histone H3 Tb927.1.2430 2.7 1.5
Rab5a Tb10.389.0550 2.6 9.5
RabX3 Tb11.01.6670 2.5 3.5
40S ribosomal protein S25 Tb927.3.1370 2.2 1.2
Amphiphysin Tb11.01.6740 2.2
Hsp70 Tb927.6.3740 2.0
cysteine peptidase Tb927.6.960 2.0
COPI epsilon Tb11.01.6530 2.0 2.6
adenylate kinase 3 Tb10.70.5150 2.0 3.1
CBL-interacting protein kinase 9 Tb927.8.870 (2.3) 1.6
Ubiquitin conjugating Tb11.02.0815 (2.1) 1.6
ARPC5 Tb10.406.0320 (2.0)
Rab5AQL overexpressing PCF line vs PCF WT histone H3 Tb927.1.2430 2.3 1.6
40S ribosomal protein S25 Tb927.3.1370 2.1 1.1
Rab5a Tb10.389.0550 2.0 9.8
adenylate kinase 3 Tb10.70.5150 1.6 3.8
alpha tubulin Tb927.1.2400 1.6 2.1
COPI epsilon Tb11.01.6530 1.4 3.0
RabX3 Tb11.01.6670 1.3 3.4
mitochondrial intermediate peptidase Tb10.6k15.0490 (2.4)
mitochondrial zinc metallopeptidase Tb927.4.3300 (2.0)
Rab5BQL overexpressing PCF line vs PCF WT Rab5b Tb11.02.2160 2.5 16.7
adenylate kinase 3 Tb10.70.5150 1.6 3.5
COPI epsilon Tb11.01.6530 1.5 3.4
RabX3 Tb11.01.6670 1.5 2.8
The most significantly altered mRNAs detected by microarray for differing serum conditions, dithiothreitol and tunicamycin treatment, RNAi of 
VSG or CLH, and Rab5 overexpressing PCF lines are shown. The ratios obtained by qRT-PCR for selected transcripts are also shown. Ratios are 
given on a linear (not log) scale, and those indicating a reduction compared to the control state are in parentheses. Only ORFs that display at least 
a two-fold change, by either qRT-PCR or array, are included; except the 4 hour DTT treatment, where only the top ten hits are shown. Ratios 
which correspond to a value >1 for the B-statistic in limma analysis are shown in bold.
Table 2: Expression changes accompanying environmental challenge in T. brucei. (Continued)Page 15 of 28
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BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298significant augmentation of fluid phase and receptor-
mediated endocytic activity [116]. The expression level of
CLH was increased, providing a mechanistic explanation
for augmented endocytic activity (Figure 5A). These data
extend earlier work showing loss of CLH protein follow-
ing Rab5A or 5B knockdown in BSF [117], and demon-
strating coordinated expression of clathrin and Rab5.
Very limited differential expression was seen between
Rab5 over-expressing and control cells (Figure 5B, Table
2). Analysis by array, qRT-PCR and Western blot con-
firmed that the cell lines were overexpressing Rab5A or
Rab5B but only detected significant upregulation for
RabX3, adenylate kinase 3 (Tb10.70.5150), and COPIε
mRNAs in the Rab5AWT, Rab5AQL and Rab5BQL overex-
pressor lines (Table 2, Figure 5C), none of which are
expected as specific changes related to early endosome
activity. Further, several mRNAs implicated as altered by
array analysis failed to be validated by qRT-PCR, suggest-
ing small or insignificant changes only (Table 2). Impor-
tantly, we were unable to detect a significant increase in
CLH mRNA in any of the cell lines by qRT-PCR, despite
Scatter plots of transcriptome data from trypanosomes subjected to altered culturing conditions and other challengesFigure 4
Scatter plots of transcriptome data from trypanosomes subjected to altered culturing conditions and other 
challenges. In each case, Cy5 fluorescence is plotted on the Y-axis and Cy3 fluorescence on the X-axis. Spots with a Cy5/Cy3 
or Cy3/Cy5 ratio above two, i.e. significantly differentially expressed are highlighted in black, spots with a ratio below two are 
shown in grey. Panel A: BSF (Cy5) vs PCF (Cy3); data are identical to Figure 1 and reproduced for comparison. Panel B: BSF in 
30% FBS (Cy5) vs BSF (Cy3). Panel C: BSF (Cy5) vs BSF in 0% FBS, 5 mg/ml BSA (Cy3). Panel D: BSF (Cy5) vs BSF in 0% FBS, 5 
mg/ml, BSA 0.3 mg/ml Tfn (Cy3). Panel E: BSF in 1 mM DTT for 1 hr (Cy5) vs BSF (Cy3). Panel F: BSF in 1 mM DTT for 4 hr 
(Cy5) vs BSF (Cy3). Panel G: BSF in 5 μg/ml tunicamycin for 4 hr (Cy5) vs BSF (Cy3). Panel H: BSF in 5 μg/ml tunicamycin for 
24 hr (Cy5) vs BSF (Cy3). Panel I: VSG RNAi in BSF, induced for 24 hr (Cy5) vs uninduced (Cy3). Panel J: VSG RNAi in BSF, 
induced for 72 hr (Cy5) vs uninduced (Cy3). Panel K: CLH RNAi in BSF, induced for 24 hr (Cy5) vs uninduced (Cy3). Panel L: 
BSF (Cy5) vs MITat1.1 grown in vivo in rats (Cy3). The scatter plots for most experiments (panels B-K) indicate few transcripts 
that fall outside of the region considered as constitutive, in marked contrast to the scattergrams obtained for developmental 
changes (panel A) and in the comparison between in vitro versus in vivo BSF cultures (panel L).
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Limited differential expression in Rab5-overexpressing PCF cellsFigure 5
Limited differential expression in Rab5-overexpressing PCF cells. Panel A: Western blot analysis for the clathrin 
heavy chain (CLH) and Rab5A, for wildtype BSFs and PCFs, PCFs overexpressing Rab5A (5AWT), Rab5AQL (GTP-locked 
mutant) and Rab5BQL (GTP-locked mutant) cell lines. BiP was used as a loading control. Panel B: Scatter plots of raw data for 
representative microarrays for BSF (Cy5) vs PCF (Cy3) experiment (plot as in Figure 1 for comparison), and Rab5-overexpess-
ing lines (Cy5) vs PCF (Cy3) as indicated. Cy5 fluorescence is plotted on the Y-axis and Cy3 fluorescence on the X-axis. Spots 
with a Cy5/Cy3 or Cy3/Cy5 ratio above two are highlighted in black, spots with a ratio below two are shown in grey. Panel C: 
Relative expression levels of Rab5A, Rab5B, CLH, RabX3, COPIε, and adenylate kinase 3 (AK3) in wildtype SMBs and PCFs, 
and in the Rab5-overexpressor PCF lines, as assessed by qRT-PCR.
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BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298significant protein level changes (Figure 5). These data
suggest, firstly, that alteration of CLH levels in these cells
proceeds via exclusively post-transcriptional mechanisms
and, secondly, that despite clear perturbation to endocytic
activity, this is not reflected in an obvious or coherent
alteration to the underlying transcriptome.
Significant transcriptome alterations between in vivo and in vitro 
cultured trypanosomes
The vast majority of molecular studies on T. brucei are car-
ried out using in vitro cultures. Recently, whole-genome
microarray analysis indicated significant differences
between in vivo and in vitro cultures of the malaria parasite
Plasmodium falciparum [118]. Therefore, as an additional
investigation into the influence of culturing conditions on
intracellular transport we compared mRNA from blood-
stream form MITat1.1 trypanosomes extracted from
infected rats and from SMB cells cultured under standard
conditions. A significant number of differentially abun-
dant mRNAs are evident from the scattergram of these
arrays (Figure 4L), and limma analysis indicated that 35
ORFs are significantly upregulated in the in vitro culture,
while three ORFs are significantly downregulated (Table
3). These include ORFs for an RNA helicase, procyclin,
CAP5.5, several small GTPases and their effectors and sev-
eral kinases (Table 3). This expression pattern did not
reveal an obvious functional pattern, in the sense that
ORFs from many biological systems appeared affected. To
eliminate the possibility that these alterations arise from
cold-shock during isolation of MITat1.1 trypomastigotes,
we also extracted RNA from SMB cultures incubated at
4°C for 1 hr. We observed very few changes between nor-
mal and cold-shocked SMB cultures (Table 3), with only
CAP5.5 and a Sec34-like ORF significantly upregulated in
the cold treatment, both of which are procyclic markers.
Given the rapidity of isolation of the mRNA from
MITat1.1, which is achieved in less than one hour, and
their incubation at 4°C during the procedure, which is
expected to reduce metabolic activity, we consider these
findings to be unlikely ascribable to factors associated
with preparation of the samples as the differences in sev-
eral mRNA levels are too great to have accumulated in
such a short period. Therefore, these data highlight signif-
icant differences between in vivo and in vitro cultured
trypanosomes; this issue would be best pursued by whole
genome microarray analysis which is beyond the scope of
the present study.
Discussion
Coordinate control of gene expression is critical for life
cycle progression in trypanosomes, and extensive remod-
eling of the parasite cell is well documented. Here we used
the intracellular trafficking system as a model for tran-
scriptome changes. We selected this process on account of
well documented alterations to endocytosis accompany-
ing developmental progression, a good level of character-
ization in trypanosomes, together with, by analogy to
higher eukaryotes, the expectation that many gene prod-
ucts will collaborate in regulation. Endomembrane trans-
port involves ~10% of the protein coding potential within
the eukaryotic genome [119,120] and position and time-
dependent targeting, assembly of macromolecular com-
plexes and cytoskeletal interactions all participate in con-
trolling a system demanding high fidelity in delivery of
molecules to specific subcellular destinations. Further, in
higher eukaryotes, transcriptional flexibility and coordi-
nation are associated with intracellular transport
[17,121]. Due to the polycistronic mode of transcription
in trypanosomes, changes in relative levels of mRNAs
result primarily from alterations in the efficiency of nas-
cent RNA processing or half-life [13]. Here we detected
clear evidence for developmental alterations to the
trypanosome transcriptome, but found very little flexibil-
ity within a given life stage.
Firstly, ~6% of transport-associated transcripts are devel-
opmentally regulated, a greater fraction than reported for
genome-wide transcription [14]. These data indicate that
developmental remodeling of endomembrane transport
is underpinned by alterations to mRNA abundance, as
expected. We also observed prominent differential expres-
sion of transport-associated mRNAs between trypano-
somes cultured in vitro and those isolated from a
mammalian host. A greater proportion of mRNAs were
upregulated in the bloodstream stage compared to the
insect form, correlating with increased endocytic activity.
Prominent upregulated factors include Rab GTPases and
SNAREs; significantly, simple upregulation of Rab and/or
SNARE proteins is sufficient to augment specific transport
pathways [116,122-124]. While the cohort of upregulated
mammalian stage mRNAs is consistent with increased
endocytic activity, there is evidence that the Rab5/Rab11
VSG endocytosis and recycling system [25,122,125] is
only part of the developmental change. For PCFs, the
upregulated cohort is consistent with lysosomal degrada-
tive pathways playing a more prominent role [26]. Direct
examination of several of the gene products implicated
here is clearly required for a more detailed understanding
of trypanosome differentiation.
Secondly, and in clear contrast, extremely limited changes
to mRNA levels were encountered in response to a wide
variety of altered states, including major changes to cultur-
ing conditions, insult with agents disrupting protein fold-
ing and RNAi of critical mRNAs encoding factors essential
for endocytosis and cell surface maintenance. Despite
polycistronic transcription, a priori there is no compelling
reason to assume that turnover of mRNA is uncoupled
from signaling systems and, moreover, the observation
that iron-deficiency leads to increased expression of thePage 18 of 28
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vides a potential example of signal-mediated changes to
mRNA abundance  [45,65,105]. Analysis of a large gene
cohort indicates that the transferrin receptor is a special
case, and we were unable to find compelling evidence for
alterations to levels of most mRNAs. The transferrin recep-
tor genes are located in an RNA Pol I-transcribed subtelo-
meric array [126] and thus may be regulated differentially
from most genes that are transcribed by RNA Pol II [127].
We also observed mRNA level alterations in a further Pol
I-derived transcript, procyclin, in response to several chal-
lenges, but we note that procyclin expression is unusually
sensitive to many factors (for example [128]). Regardless
of these exceptions, our data indicate that the vast major-
Table 3: Expression changes associated with in vivo versus in vitro culture of T. brucei.
MiTat vs SMB Gene Accession Fold difference
up in SMB DHH1 Tb10.70.3290 6.2
procyclin Tb927.6.450 5.0
PRA1 Tb10.389.1550 4.1
procyclin Tb10.6k15.0030 3.8
CSNK1D (casein kinase) Tb927.5.800 3.6
CAP5.5 Tb927.4.3950 3.5
Rab1a Tb927.8.890 3.5
SNF1-like kinase Tb10.70.1760 3.5
cofilin (ADF) Tb927.3.5180 3.1
NEK2/6/7 kinase Tb927.3.3190 3.0
PI3K (FYVE) Tb11.01.6980 2.8
Trs20/sedlin Tb927.8.5900 2.7
Ser peptidase (Bem46-like) Tb09.211.2310 2.7
Ubiquitin conjugating Tb11.02.0815 2.6
AP4 sigma Tb10.61.2530 2.6
ARPC5 Tb10.406.0320 2.6
FYVE Zn finger containing protein Tb927.4.3380 2.5
ARPC4 Tb927.2.2900 2.5
GSK3B kinase Tb927.7.2420 2.5
IFT88 Tb11.55.0006 2.3
RabGAP Tb10.6k15.1770 2.3
nuclear transport factor 2 Tb10.70.5500 2.3
ISG65-like Tb927.5.410 2.3
two UIM domains Tb10.70.1130 2.2
t-SNARE Tb11.03.0965 2.2
Rab7 Tb09.211.2330 2.2
CBL-interacting protein kinase 9 Tb927.8.870 2.2
VHS domain containing protein Tb11.01.2540 2.2
GTP1/OBG/Hsr1 Tb927.2.4240 2.1
Hsr1/GTP-binding Tb927.7.2630 2.1
MAPK8 kinase Tb10.70.2070 2.1
PABP2 Tb09.211.2150 2.1
calreticulin (lectin) Tb927.4.5010 2.0
RanGEF Tb927.8.7290 2.0
ARL3A Tb927.3.3450 2.0
up in MiTat1.1 p67 Tb927.5.1810 2.0
polyUb Tb11.01.1680 2.0
RanGEF Tb10.6k15.3150 2.9
SMB 4°C vs SMB Gene Accession Fold difference
up in 4°C CAP5.5 Tb927.4.3950 2.3
Sec34-like Tb927.7.2640 2.0
Significantly differentially expressed transcripts for in vivo MITat1.1 bloodstream culture vs in vitro SMB culture, and for SMB treated at 4°C for one 
hour. Ratios are given on a linear scale. Only ORFs which show at least a two-fold change are shown. Ratios which correspond to a value >1 for the 
B-statistic in limma analysis are shown in bold.Page 19 of 28
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that, for most messages, transcription and turnover are
unaffected by signaling pathways. This implies that the
trypanosome has a very limited capacity to respond to
altered circumstances in vivo, except via pre-programmed
differentiation pathways.
The absence of transcriptome responsiveness to environ-
mental cues has several consequences. Firstly, lack of a
classical UPR indicates ER insensitivity to increased con-
centrations of non-native polypeptides, and implies that
changes in biosynthetic output similarly will not be
sensed. This is consistent with extreme sensitivity to con-
centrations of DTT that are well tolerated in higher
eukaryotes. Whether the UPR is absent from additional
excavates is unknown, but preliminary evidence suggests
that Giardia also lacks the pathway [112]. Secondly, fail-
ure to modify the transcriptome following gene knock-
down or over-expression, but where a major impact on
transport is found, suggests that modulation of traffick-
ing, and potentially other systems, within a given life stage
is restricted to proteomic changes [117]. Thirdly, and
most significantly, the data indicate an inability of the
trypanosome endomembrane system to adapt to altering
conditions and, coupled with the possibility that such
unresponsiveness extends to additional cellular functions,
has profound implications.
Limited transcriptional flexibility is clearly a restriction for
the trypanosome, but is in agreement with a modest small
GTPase signaling network [30], which may indicate a
rather limited signal transduction capacity. As each life
stage exists within a highly controlled environment the
trypanosome's ability to modulate the trafficking system
has likely been lost. The environment within the insect
host is poorly understood, but the bloodstream pH range
in H. sapiens is 7.35 – 7.45, blood glucose is at 4 – 8 mM
and transferrin concentration is maintained at ~300 ± 50
μg/dl [129]; major alterations to these parameters are
lethal, and hence there is little need for the parasite to
retain mechanisms for responsiveness. By contrast, a new
transcriptome would be triggered by appropriate signals
when the trypanosome enters a new compartment or
host. Hence the trypanosome life cycle may be viewed as
a set of inflexible, sequential transcriptional profiles that
serve to adapt the parasite to each new environment (Fig-
ure 6). The in vitro cultured BSF is a convenient model for
the mammalian bloodstream trypomastigote but, during
infection, trypanosomes also invade tissue spaces, the
lymphatic system and, in later disease stages, the cerebral
spinal fluid [1]. Each environment differs greatly from the
bloodstream in composition and hence transcriptome
inflexibility suggests that a differentiation event may be
required for adaptation. Further, the major transcriptome
differences between cultured and animal-isolated
trypanosomes underscores the potential for currently
uncharted, but dramatic, adaptations associated with
mammalian infection.
A similar transcriptional rigidity is suggested for the intra-
erythrocytic stages of the malaria parasite, Plasmodium fal-
ciparum, possibly also related to the fact that Plasmodium
enjoys a homeostatic host environment [130-132].
Trypanosomatids (Excavata) and Plasmodia (Chromalve-
olata) are highly divergent and separated by many non-
parasitic or free-living species, and thus transcriptome
unresponsiveness most likely is the result of independent
secondary loss accompanying adoption of the parasitic
life style. Consistent with this view, environmental stress
treatments do induce transcriptional responses in Euglena
gracilis [133], a free-living protist closely related to kineto-
plastids. Further, as Plasmodium utilises a more conven-
tional promoter-mediated mechanism for transcription,
this also rules out a trivial explanation that transcriptome
inflexibility is simply the result of polycistronic transcrip-
tion. Examination of transcriptome regulation in more
free-living organisms related to both Plasmodium and
trypanosomes would be highly informative.
Finally, these data indicate that knockdown of a specific
mRNA does not alter the transcript levels of additional
gene products coordinated functionally with the RNAi tar-
get. Therefore, in T. brucei RNAi is unlikely to suffer from
off target effects as seen in higher eukaryotes [134-136],
and hence is, in this regard, unusually clean. Secondary
effects are likely mediated via proteome changes, and
could explain the similar phenotypes observed for many
knockdowns [61]. This is particularly prominent for cell
cycle/cytokinesis defects that frequently emerge rather late
following knockdown. Such effects may be the result of
generic loss of the normal proteome, rather than absence
of specific factors.
Conclusion
The life cycle of T. brucei includes a dramatic differentia-
tion event as the parasite progresses from the insect to the
mammalian host. Differentiation encompasses consider-
able remodeling of the membrane trafficking system,
which is also a vital component of the host-parasite inter-
face. Using a subgenome microarray targeting the T. brucei
trafficking systems together with qRT-PCR analysis, we
find clear evidence for developmental alteration to ~6%
of the trypanosome transport-associated transcriptome.
This indicates that developmental remodeling of
endomembrane transport is underpinned by alterations
to mRNA abundance, and that such changes may be ana-
lysed by microarray. Most protein-coding mRNAs in
trypanosomatids are produced by polycistronic transcrip-
tion, with specific rates of decay as the major mechanism
controlling steady state transcript levels. Multiple stimuli,Page 20 of 28
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with agents disrupting protein folding, and RNAi of criti-
cal mRNAs encoding factors essential for endocytosis and
cell surface maintenance, elicited extremely limited
changes to the transcriptome. Besides alterations in
expression of the transferrin receptor upon iron stress,
which is transcribed by Pol I, the vast majority of trypano-
some chromosomal Pol II-derived mRNAs are unmodu-
lated. These findings imply a very limited capacity of
trypanosomes to respond to altered circumstances in vivo,
except via pre-determined differentiation pathways (Fig-
ure 6). Hence mRNA levels are insensitive to external
stimuli and most responses are mediated at the proteome
level. These data suggest a new view of the trypanosome
life cycle as a progression through sequential, inflexible
transcriptional profiles that serve to adapt the parasite to
each new host environment. As similar transcriptional
rigidity is suggested for the malaria parasite, Plasmodium
falciparum, but transcriptional flexibility is found in the
closely related and free-living protist, Euglena gracilis, it is
likely that loss of transcriptional flexibility arose through
the parasitic lifestyle.
Methods
Open reading frame selection
We selected ORFs encoding components of the trypano-
some transport system using the geneDB interface [137].
The genome was parsed with four criteria; (i) annotation
keywords, including description information and wild-
cards, for protein classes involved in endocytosis and
membrane trafficking (e.g. clathrin, adaptin, SNARE, Rab,
ADP-ribosylation factor, coatomer, Sec, Vps), (ii) Pfam/
Interpro domain annotation (e.g. ARF/SAR superfamily,
C2, ENTH, PH, SH3, SNF7, VHS, BAR), (iii) "Biological
Process" Gene Ontology (GO) annotation (e.g. endocyto-
sis, vesicle mediated transport, GTPase activity) and (iv)
sequence similarity by BLAST. The target gene selection
was augmented by parsing the literature for candidate fac-
tors, i.e. yeast and mammalian proteins that have been
functionally demonstrated to be involved in trafficking.
We thus identified 673 ORFs for inclusion.
Array construction
Oligonucleotides were designed with OligoArray 2.0
[138] specifying a 67 mer within one kilobase of the 3'-
Transcriptional flexibility and inflexibility in differentiation and responsivenessFigure 6
Transcriptional flexibility and inflexibility in differentiation and responsiveness. Upper panel: flexible system. Gene 
cohorts 1 and 3 are developmentally regulated, and either highly expressed or not expressed; examples of these types of gene 
products are the trypanosome surface antigens, VSG in the bloodstream form (red) and procyclin in the insect stage (green). 
The vast majority of genes fall into cohort 2, where, for example, either small or large changes to transcription could result 
from alterations to the environment (light and dark blue), or a more continually altering transcriptional profile is present that 
may seek to track changing conditions (purple). This behavior may propagate from one life stage to the next (light and dark 
blue) or be lost (purple) resulting in altered transcriptional flexibility for genes between life stages. Such a profile is found in 
higher eukaryotes, including humans and yeast, and probably also many protists, including E. gracilis. Lower panel: inflexible sys-
tem. In this model gene cohorts 1 and 3 behave as before, but transcription of the genes in cohort 2 remains unchanged. The 
relative levels of mRNAs from the genes in this cohort may remain constant following differentiation (light blue) or be signifi-
cantly altered (dark blue and purple). Such a profile is observed here for T. brucei and has been reported previously for P. falci-
parum, and is potentially a result of a parasitic life style where the host is responsible for provision of a homeostatic 
environment.
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otides were designed, targeting 796 genes (several ORFs
are multicopy and hence multiple transcripts are sampled
by a single oligonucleotide in such cases). The array
encompassed 56 oligonucleotides targeting 123 reference
ORFs, whose expression pattern has been established pre-
viously. Oligonucleotides were manufactured by Illumina
(Invitrogen) and included a 5' amino modification for
attachment to Codelink activated slides (GE Healthcare).
Arrays were printed using a BioRobotics Microgrid
(Genomic Solutions) equipped with 16 NanoPins (Matrix
Technology Corporation) in the Centre for Microarray
Resources, Department of Pathology, University of Cam-
bridge. Slides were prepared, washed and dried according
to the manufacturer's instructions (GE Healthcare). Each
oligonucleotide was spotted in quadruplicate, while α-
and β-tubulin were spotted at the corners of the grid and
reference oligonucleotides and additional spotting con-
trols (empty, water, spotting buffer) were distributed ran-
domly.
Cells, in vitro and in vivo culture conditions
Cultures of T. brucei brucei Lister 427 single marker blood-
stream form (SMB) and procyclic form (PCF) strain 427
were maintained in HMI-9 (Invitrogen) and SDM-79
(Sigma) media, respectively [139-141]. Rab5A and Rab5B
over-expressing PCF lines have been described previously
[116]. A VSG knockdown line was generated by expres-
sion of a double strand fragment of the 221 VSG ORF
(PCR primers: TTTCTGCAGCGGTCACTATG and TGCTT-
GTTGTTGGCTTTCAG) cloned into Eam1105I-digested
p2T7TABlue [61]. Tetracycline-responsive SMB cells were
transfected with NotI-digested p2T7TABlue-VSG by electro-
poration, selected and maintained with 2.5 μg/ml G418
and 2.5 μg/ml hygromycin. RNAi was induced by adding
1 μg/ml tetracycline. The clathrin RNAi BSF line was gen-
erated as described [114] except that the TbCLH gene frag-
ment was subcloned into the p2T7TA vector [114] and an
Amaxa nucleofector was used for transfection [142].
Transformants were maintained under 2.5 μg/ml neomy-
cin and 2.5 μg/ml hygromycin selection, and RNAi was
induced by adding 1 μg/ml tetracycline. For treatment
with dithiothreitol (DTT) and tunicamycin, SMB cells
were grown in HMI-9 to 1 × 106 cells/ml, and the media
supplemented with either DTT (Sigma) at 1 mM, or tuni-
camycin (Sigma) at 5 μg/ml. Samples for RNA extraction
were taken after 1 hr and 4 hr for DTT addition and 4 hr
and 24 hr for tunicamycin. To assess the influence of
serum on gene expression, cells were grown in standard
media until a concentration of 1 × 106 was reached and
harvested by centrifugation at 800 g for 10 minutes. The
cell pellet was re-suspended in media lacking fetal bovine
serum (FBS), and supplemented with 5 mg/ml BSA with
or without 0.3 mg/ml bovine holo-transferrin (Sigma), to
simulate physiological concentrations of albumin and
transferrin in media supplemented with 10% FBS [129].
For 30% FBS treatment cells were grown in HMI-9 media
supplemented with 30% FBS.
For in vivo grown cells, the blood from rats infected with
monomorphic bloodstream forms (MITat1.1 at 1 × 109
cells/ml parasitemia) was taken by aortic puncture into
heparinized syringe. The buffy coat fraction was prepared
by centrifugation of infected blood (600 g, 10 min at
4°C). All subsequent treatments were performed at 4°C.
Trypanosomes were purified from the buffy coat using
PSG (NaH2PO4 3 mM, Na2HPO4 50 mM, NaCl 44 mM,
sucrose 100 mM, adenosine 0.1 mM, pH 8.0). The cells
were washed three times in PSG and then resuspended at
109 cells/ml.
RNA extraction
RNA was extracted using the Qiagen RNeasy kit following
the manufacturer's instructions. 1 × 108 BSF (SMB) or 5 ×
107 PCF cells were used per extraction. RNA quantity and
quality was measured using a NanoDrop ND-1000 (Nan-
oDrop Technologies) and denaturing formaldehyde agar-
ose gels [143] prior to further analysis. For the MITat1.1
cells, RNA was prepared using the Absolutely RNA kit
(Stratagene) according to the manufacturer's instructions.
Array hybridization
For each experiment, hybridisations were performed with
at least three biological replicates with Cy3/Cy5 dye-
swaps. Preparation of amplified and labelled cDNA tar-
gets were essentially as described [144] except that Ampl-
iTaq DNA polymerase Buffer II (Applied Biosystems) was
used for the cDNA amplification. Following hybridisa-
tion, slides were washed for 5 min in 2 × SSC, 5 min in 0.1
× SSC/0.1% SDS, 5 min in 0.1 × SSC and rinsed in dH2O.
All washes were performed at room temperature. After
washing, slides were dried by centrifugation and scanned
on an Axon 4100 scanner using GenePix software (Molec-
ular Devices). Fluorescence intensity was normalised so
that the total signal for the Cy3 and the Cy5 channels were
equivalent. Raw image data were extracted using Bluefuse
(BlueGnome).
Array data analysis
To identify significant differential expression, the microar-
ray data were analysed using limma (version 2.4.7) [50]
from the Bioconductor open-source project [49] running
under R (version 2.2.1), and a custom program written by
K. Kelly (Cambridge). Data pre-processing comprised
within-array print-tip Loess normalisation and between-
array scale normalisation. To identify differentially
expressed mRNAs a linear model was fitted to the data,
using as weights the square root of the "confidence" value
given by Bluefuse for each spot (which depends on the
area, circularity and uniformity of the spot, signal to noisePage 22 of 28
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Cy5 ratio in different pixels across the spot). Adjustment
for multiple testing was carried out using the false discov-
ery rate (FDR) method [145] in limma. For clustering
analysis, data from the Bluefuse analysis were processed
using the Gene Expression Pattern Analysis Suite (GEPAS)
[146,147] using the DNMAD and SOTARRAY programs.
Replicates were merged after filtering replicates with val-
ues > 0.5 – 1.0 above the median of replicates. Hierarchi-
cal clustering was performed using UPGMA and Euclidian
distance with settings at normal.
Quantitative real time (qRT)-PCR
For cDNA synthesis, 2 μg RNA was diluted to 10 μl with
diethylpyrocarbonate (DEPC)-treated water and dena-
tured at 70°C, 5 min. 15 μl of a reaction mix was added
(2.5 μl dNTPs (25 mM stock), 5 μl 5× reverse transcription
buffer (Invitrogen), 2 μl 100 mM DTT, 0.5 μl RNAseOUT
(recombinant ribonuclease inhibitor, 40 U/μl, Invitro-
gen), 2 μl oligo dT (T30VN, 10 μM stock), 0.5 μl Super-
script II Reverse Transcriptase (200 U/μl Invitrogen), and
2.5 μl DEPC-treated water) and incubated at 37°C for 1
hr, heat-inactivated at 90°C, 5 min and finally diluted to
200 μl with DEPC-treated water.
For qRT-PCR, 5 μl of cDNA was used in a 25 μl reaction
including IQ SYBR Green Supermix (BioRad) with 0.4 μM
gene-specific forward and reverse primers [see Additional
file 2]. qRT-PCR reactions were performed in white thin-
wall polypropylene multiplate 96-well unskirted PCR
plates (BioRad) sealed with microseal 'B' adhesive (Bio-
Rad). Reactions were performed in a BioRad MiniOpticon
real time PCR detection system and included an initial
denaturation at 95°C for 3 min, 40 cycles of 95°C 30 sec-
onds, 58°C 30 sec, 72°C 6 min (with a signal read at the
end of each cycle), and a final melting curve to check fidel-
ity from 60 – 95°C, with a signal read every 1°C. Gene-
specific 20 bp primers for each gene were designed using
Primer3 [148] specified to amplify a ~120 bp fragment (+/
- 10 bp) in the last kilobase of the 3' end of the open read-
ing frame and coinciding with the region recognised by
the corresponding array oligonucleotide. Primer pairs
were validated in silico using Amplify [149] to minimise
the probability of mispriming or formation of primer
dimers and secondary structure.
Antibody production and Western blot analysis
TbδAd antisera was generated against an expressed gene
fragment (residues 222–508) amplified from T. brucei
genomic DNA using Herculase DNA polymerase (Strata-
gene) with the following primers: 5'-GGAATTCCCAGCT-
TCTTAGGTCTAGCGGT-3' and 5'-
CCGCTCGAGCTCAACAATAGTTCGCATGTGC-3'. The
865 bp PCR product was subcloned into pPCR-Script,
excised with EcoRI, and inserted into pGEX-2TK. Polyclo-
nal rabbit antibodies were raised against TbδAd-GST
recombinant fusion protein, which was SDS-PAGE-puri-
fied due to insolubility when expressed in E. coli, mixed
with RIBI adjuvant (Sigma) and used to immunize rabbits
on four immunisations spread over a period of five
months. 0.5 mg recombinant protein was used per immu-
nisation course.
For Western blotting, 1 × 107 trypanosome cells were har-
vested by centrifuging at 800 g, 10 min, 4°C, washed in
phosphate-buffered saline (PBS) and resuspended in 37.5
μl PBS and 12.5 μl 4× Laemmli SDS loading buffer [143].
Lysates were denatured at 95°C for 10 min and analysed
by 12.5% SDS-PAGE [143]. Equivalence of protein load-
ing was verified by Coomassie Blue staining of a duplicate
gel. Proteins were electrophoretically transferred to
Immobilon-P membrane (Millipore) using a wet transfer
tank (Hoefer Instruments). Nonspecific binding was
blocked for 1 hr with Tris-buffered saline, pH 7.4, 0.2%
Tween (TBST) supplemented with 5% freeze-dried milk.
The membrane was then incubated for 1 hr with primary
antibody, also diluted in TBST-milk. Rabbit polyclonal
antibody against trypanosome BiP (a kind gift of James
Bangs, University of Wisconsin) or the trypanosome
clathrin heavy chain [16] were used at 1:1,000 dilution,
and rabbit anti-TbδAd (see above) at 1:1,000. After wash-
ing 3 times for 5 min in TBST, a commercial secondary
anti-IgG rabbit horse-radish-peroxidase conjugate
(Sigma) was used at 1:10,000 in TBST for 1 hr, and
bound-antibodies were detected on Biomax MR-1 films
(Kodak) using H2O2-activated Luminol (Sigma) in 100
mM Tris pH 8.5.
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Additional file 1
Absence of clustering of membrane-trafficking genes in the T. brucei 
genome. Panel A: The number of genes identified on each chromosome 
predicted to have a role in membrane traffic based on sequence similarity 
and/or domain architecture are plotted against chromosome size (in Mb). 
Multicopy genes are represented here as a single gene. Panel B: Raw data 
on which plot A is based. Approximate chromosome sizes are from 
GeneDB.
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Additional file 2
Details of open reading frame selection, microarray oligonucleotides, 
qRT-PCR primers, database annotation and prior work. Functional 
groups assigned based on likely orthologs and/or domain annotation from 
multiple sources. Accession numbers are for T. brucei 927 at GeneDB, 
except ESAG6 and ESAG7 which are for T. brucei 427 at GeneDB, and 
VSG oligonucleotides which are based on sequences deposited at NCBI. 
All oligonucleotide sequences are given in 5'-3' orientation. Array version 
1.0 was used for the bloodstream v procyclic comparison and analysis of 
the Rab5 overexpressor lines; array version 1.1 used in all other experi-
ments. The "Cross-hybridising ORFs" column gives the GeneDB accession 
numbers of ORFS likely to cross-hybridise to each oligonucleotide, when 
applicable, as predicted by the OligoArray 2.0 program. qRT-PCR oligo-
nucleotide sequences are given for all ORFs analysed by qRT-PCR.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-298-S2.xls]
Additional file 3
Developmental regulation of components of the adaptin complexes 
AP1, AP3, and AP4 in T. brucei. Panel A: Heatmap of bloodstream ver-
sus procyclic form signal ratios for the ORFs corresponding to the adaptin 
complexes, based on eight microarray experiments. For each target gene, 
the four replicate spots on the array were averaged, following removal of 
inconsistent replicates. The scale shows the colour scheme for the z-score 
of the data, indicating how far and in what direction, the ratio for each 
spot deviates from the mean for each array, expressed in units of standard 
deviation; bright red indicates significant upregulation in BSF, bright 
green indicates significant upregulation in PCF, dark colours or black 
indicate no differential expression between the two developmental stages. 
AP1σ is highly upregulated in BSF, and AP3μ in PCF (also see Table 1) 
with a general trend of BSF upregulation for AP1 components and PCF 
upregulation (or BSF downregulation) for AP3 and AP4 components. 
Panel B: Western blot analysis of whole cell lysates from BSF (lane B) and 
PCF (lane P) (1 × 107 cell equivalents) probed with rabbit antisera raised 
against recombinant TbδAd adaptin subunit (AP3). The scale to the left 
represents relative molecular mass in kDa. The predicted molecular weight 
for the AP3δ protein is 125 kDa. Loading equivalence was monitored by 
Ponceau Red staining of the membrane after transfer (not shown).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-298-S3.pdf]
Additional file 4
Response of T. brucei cells to dithiothreitol and tunicamycin treat-
ment. Panel A: Growth curves for BSF cultures after the addition of dithi-
othreitol (DTT, 1–10 mM final concentrations) or tunicamycin (5–10 
μg/ml final concentrations). Cell numbers diminish rapidly after the addi-
tion of DTT (within 4 hours), whereas cell growth is arrested after addi-
tion of tunicamycin and cell numbers remain stable for up to 24 hours. 
Panel B: Western blot analysis of whole cell lysates (1 × 107 cell equiva-
lents) for BiP in a control culture, as well as cultures supplemented with 
1 mM DTT and 5 μg/ml tunicamycin. A culture of BSF cells was divided; 
one flask was retained as control and DTT or tunicamycin was added to 
the other subcultures. Samples were taken prior to DTT or tunicamycin 
addition (C0), 1 hr and 4 hr after DTT treatment (D1 and D4, respec-
tively), 1 hr, 4 hr and 24 hr after tunicamycin treatment (T1, T4 and 
T24), and at 1 hr, 4 hr and 24 hr from the control (C1, C4, C24). Panel 
C: BiP protein levels normalised to total protein, based on the Western blot 
in panel B and two additional replicates. The levels of BiP antigen are nor-
malized to 100% for the control culture at time zero (C0). Panel D: Rel-
ative levels of BiP mRNA as measured by qRT-PCR after DTT (black 
bars) and tunicamycin (grey bars) treatment. The levels of BiP mRNA are 
normalized to 100% for the control culture at time zero (C0).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-298-S4.pdf]
Additional file 5
Verification of phenotypes for VSG and CLH RNAi cell lines. Panel A: 
Growth curves of induced versus uninduced VSG RNAi cell lines, indicat-
ing growth arrest in the induced cell line over four days post induction. 
Panel B: CLH protein levels in induced (+Tet) versus uninduced (-Tet) 
CLH RNAi cell lines were examined by Western blotting. BiP was used as 
a loading control. Data from two biological replicates are shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-298-S5.pdf]
Additional file 6
Significantly developmentally expressed trypanosome genes grouped 
by functional class. Numbers of transcripts on which the graph in Figure 
2 is based. The number of genes for each functional class correspond to the 
ORFs featured in Table 1 and discussed in the text. Note that several of 
the oligonucleotides on the array target multicopy genes (e.g, tubulin, his-
tones) and thus the total number of ORFs subject to differential regulation 
is higher than the number of ORFs/oligonucleotides given in Table 1.
Click here for file
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MEXP-1529, E-MEXP-1530, E-MEXP-1533, E-MEXP-1539, E-MEXP-1540.
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